NAM works hard to make sure it receives its funding from a wide range of sources so it does not rely too heavily on any one funder. This means we can be confident that our future will not be jeopardised by a funder unexpectedly withdrawing its support. It also affords us a great deal of scope to undertake projects that could otherwise be restricted. But most importantly, it means that you can be confident that the information we produce will always be impartial, accurate and reliable.

We are fortunate to receive some funds from the pharmaceutical industry, which has been generous in supporting community-based HIV treatment information work. Their support is long-standing and has provided security in a rapidly changing funding environment. However, we have strict funding guidelines in place to ensure the independence and impartiality of all our information. The grants they provide are towards our wider programme only (allowing us to apply them to our various resources as we see fit) and there is no question of their being able to interfere with our editorial stance or influence us in any other way that undermines our independence. The pharmaceutical companies understand and honour our position on this.

However, this year we need to raise 1.1 million pounds to fund our vital information services. Roughly 18% will come from sales of our resources to professionals working in the HIV sector, 31% from the UK government, 22% from pharmaceutical and biotech companies and 22% from charitable trusts. The remainder is down to the generosity of individuals.

NAM launched its individual fundraising scheme in 2004. This has been a great success and our thanks go out to everyone who has generously donated to NAM. Support like this makes a huge difference and will enable us to reach even more people with essential HIV treatment information. If you would like to support NAM's work and help people live longer, healthier lives, visit our donation page.

NAM's funders 

• Abbott Laboratories Ltd 

• Abbott Fund

• Allan & Nesta Ferguson Charitable Trust

• Avexa Ltd  

• Boehringer Ingelheim Ltd  

• Bristol-Myers Squibb Pharmaceuticals Ltd 

• Cavidi AB

• Delphic Diagnostics Ltd

• Derek Butler Trust

• Government of the United Kingdom, Department of Health

• Government of the United Kingdom, Department for International Development

• Diana, Princess of Wales Memorial Fund

• Elton John AIDS Foundation

• Estate of Sidney Klieff

• F. Hoffmann-La Roche Ltd

• Gilead Sciences Ltd

• GlaxoSmithKline PLC

• GlaxoSmithKline's Positive Action 

• Hugh Fraser Foundation

• Lloyds TSB Foundation for Northern Ireland

• Manchester City Council

• Merck & Co., Inc.

• Merck Sharp & Dohme Ltd

• Merck Sharp & Dohme Romania SRL

• Miss Agnes Hunter’s Charitable Trust

• NHS Ashton, Leigh & Wigan

• NHS Birmingham East and North

• NHS Bolton

• NHS Brighton & Hove

• NHS Manchester

• NHS Norfolk

• NHS Pan-London HIV Prevention Programme  

• NHS Salford

• NHS South East Essex

• NHS South West Essex

• NHS West Sussex

• NHS Worcestershire Health Services

• Pfizer Ltd

• Roche Molecular Systems, Inc.

• Roche Products Ltd

• Sanofi Pasteur MSD

• Schering-Plough Corporation

• Tibotec (a division of Janssen-Cilag) Ltd

• UNAIDS

• World Health Organization

And of course, we would also like to acknowledge the generous support of individual donors. To find out more about supporting NAM, click here.